echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Nat Genet: HPV subsypes may affect treatment and prognostication in patients with cervical cancer.

    Nat Genet: HPV subsypes may affect treatment and prognostication in patients with cervical cancer.

    • Last Update: 2020-09-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    14, 2020 // -- In a recent study published in the international journal Nature Genetics, scientists from the University of British Columbia and others analyzed women with cervical cancer in Uganda and found that there may be significant genomic differences between tumors caused by different human papillomavirus (HPV), suggesting that the type of HPV may affect the disease characteristics and treatment prognosis of cervical cancer patients.
    Photo Source: Unsplash/CC0 Public Domain For the first time, researchers conducted the first comprehensive analysis of the molecular characteristics of cervical cancer in African populations, comparing samples of cervical cancer infected with different evolutionary-related HPV strains (HPV branches) and finding previously unknown differences and revealing how HPV branches affect human genome characteristics, HPV-16 and HPV-1 8 belongs to the virus A9 and A7 differentiation branches, these two HPV virus subtypes are the most common cause of cervical cancer, at least 70% of cancer cases are related to these two HPV subtypes, although HPV-16 and HPV-18 are considered to have a higher risk of cancer, but HPV-18 is often associated with more clinically invasive cancer.
    researcher Marco Marra said: 'We are very pleased to be able to use genomic technology to analyze very valuable samples from cervical cancer patients in Uganda, HPV infection is the main cause of death in cervical cancer patients, in British Columbia, the incidence of cervical cancer in the population will be due to H PV vaccinations and routine screening have declined, but cervical cancer remains the fourth most common type of cancer in the world and the most common cause of cancer-related deaths among women in sub-Saharan Africa, with researchers predicting that the death rate among cervical cancer patients will rise to 50 percent by 2040.
    Finally, researchers say it's important to study cervical cancer in African populations, and they'll link the findings to other HPV-related cancers, such as head and neck cancer, which are becoming more common in Western populations.
    will continue to study further the molecular mechanisms that reveal the effects of HPV strains on the treatment and prognostication of patients with cervical cancer.
    () Originals: Gagliardi, A., Porter, V.L., Zong, Z. et al. Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes. Nat Genet 52, 800-810 (2020). doi:10.1038/s41588-020-0673-7.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.